A Study of LY3502970 in Participants With Impaired and Normal Liver Function

Summary

The main purpose of this study is to measure how much of LY3502970 gets into the bloodstream and how long it takes the body to eliminate it in participants with mild, moderate and severe impaired liver function compared to participants with normal liver function. The safety and tolerability of LY3502970 will also be evaluated. The study may last up to 6 weeks for each participant including the screening period.

Timeline

Start

2023-06-13

Primary completion

2024-11-18

Completion

2024-11-18

Drugs

Indications